The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc
Open accessAbstract
It is well established that high doses of monomeric immunoglobulin G (IgG) purified from pooled human plasma [intravenous immunoglobulin (IVIG)] confer anti-inflammatory activity in a variety of autoimmune settings. However, exactly how those effects are mediated is not clear because of the heterogeneity of IVIG. Recent studies have demonstrated that the anti-inflammatory activity of IgG is completely dependent on sialylation of the N-linked glycan of the IgG Fc fragment. Here we determine the precise glycan requirements for this anti-inflammatory activity, allowing us to engineer an appropriate IgG1 Fc fragment, and thus generate a fully recombinant, sialylated IgG1 Fc with greatly enhanced potency. This therapeutic molecule precisely defines the biologically active component of IVIG and helps guide development of an IVIG replacement with improved activity and availability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On the other hand, galactose is required for sialylation with N-acetylneuraminic acid (NeuAc), which in turn can improve the solubility, anti-inflammatory activity, thermal stability and serum half-life of mAbs [8,23–26].”
From Glycoengineering Chinese hamster ovary cells: a short history (2021) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“it is the α2,6-linked NeuAc (main sialic acid linkage in human IgG) that is solely required for the anti-inflammatory activity of IgG mediated by non-canonical IgG-Fc receptors [24].”
From Glycoengineering Chinese hamster ovary cells: a short history (2021) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siglecs and their roles in the immune system
Crocker, P. R., Paulson, J. C., & Varki, A. P. (2007) · Nature reviews. Immunology · doi:10.1038/nri2056 · Cited by 2,032
Self-citationAnti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754
Self-citationThe Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins
Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., & Dwek, R. A. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141702 · Cited by 1,354
Divergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding
Nimmerjahn, F., & Ravetch, J. V. (2005) · Science · doi:10.1126/science.1118948 · Cited by 1,057
Self-citationAnti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor
Samuelsson, A., Towers, T. L., & Ravetch, J. V. (2001) · Science · doi:10.1126/science.291.5503.484 · Cited by 1,051
Self-citationGlycan-based interactions involving vertebrate sialic-acid-recognizing proteins
Varki, A. P. (2007) · Nature · doi:10.1038/nature05816 · Cited by 855
From Systemic T Cell Self-Reactivity to Organ-Specific Autoimmune Disease via Immunoglobulins
Korganow, A., Ji, H., Mangialaio, S., Duchatelle, V., Pelanda, R., Martin, T., Degott, C., Kikutani, H., Rajewsky, K., Pasquali, J., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80045-x · Cited by 691
A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission
Tumpey, T. M., Maines, T. R., Hoeven, N. V., Glaser, L. J., Solórzano, A., Pappas, C., Cox, N. J., Swayne, D. E., Palese, P., Katz, J. M., et al. (2007) · Science · doi:10.1126/science.1136212 · Cited by 580
Scallon, B. J., Tam, S. H., McCarthy, S. G., Cai, A. N., & Raju, T. S. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.09.005 · Cited by 413
Influenza Virus Receptor Specificity and Cell Tropism in Mouse and Human Airway Epithelial Cells
Ibricevic, A., Pekosz, A. S., Walter, M. J., Newby, C. M., Battaile, J. T., Brown, E. G., Holtzman, M. J., & Brody, S. L. (2006) · Journal of Virology · doi:10.1128/jvi.02677-05 · Cited by 399
Cited by
Sorted by citations
Items 601–700 of 847
Bailey, E. M., Choudhury, A., Vuppula, H., Ortiz, D. F., Schaeck, J. J., Manning, A. M., Bosques, C. J., & Hoppe, A. D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.617767 · Cited by 8
Lim, J.-H., Kim, J., Cha, H.-M., Kang, S.-H., Han, H., Ji, M., Cheon, S., Kang, M., Kim, H. H., & Kim, D. (2022) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2022.110007 · Cited by 8
N-Glycan Isomer Differentiation by Zero Flow Capillary Electrophoresis Coupled to Mass Spectrometry
Wagt, S., de Haan, N., Wang, W., Zhang, T., Wuhrer, M., & Lageveen‐Kammeijer, G. S. M. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c02840 · Cited by 8
Galeotti, C., Maddur, M. S., Kazatchkine, M. D., Mouthon, L., & Kaveri, S. V. (2009) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2009.03.009 · Cited by 8
Mouthon, L., Bussone, G., & Kaveri, S. V. (2009) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(09)73168-6 · Cited by 8
Naturally Occurring Antibodies/Autoantibodies in Polyclonal Immunoglobulin Concentrates
Späth, P., & Lutz, H. U. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3461-0_18 · Cited by 9
A Role for Nucleocapsid-Specific Antibody Function in COVID-19 Convalescent Plasma TherapyPreprint
Herman, J. D., Wang, C., Burke, J. S., Zur, Y., Compere, H., Kang, J., Macvicar, R., Shin, S. A., Frank, I., Siegel, D. L., et al. (2022) · medRxiv · doi:10.1101/2022.02.19.22271230 · Cited by 8
Serum immunoglobulin and the threshold of Fc receptor-mediated immune activation
Bauer-Smith, H., Sudol, A. S. L., Beers, S. A., & Crispin, M. (2023) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2023.130448 · Cited by 10
Pasricha, C., Bansal, N., Kaur, R., Kumari, P., Jangra, S., & Singh, R. J. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010310906240725072426 · Cited by 7
Predicting psychiatric risk: IgG N-glycosylation traits as biomarkers for mental health
Lv, Y., Chen, Y., Li, X., Huang, Q., Lu, R., Ye, J., Meng, W., Fan, C., & Mo, X. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1431942 · Cited by 8
Development of stage-dependent glycans on the Fc domains of IgG antibodies of ALS animals
Edri‐Brami, M., Sharoni, H., Hayoun, D., Skutelsky, L., Nemirovsky, A., Porgador, A., & Lichtenstein, R. G. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.02.023 · Cited by 7
Prezzo, A., Cavaliere, F. M., Bilotta, C., Iacobini, M., & Quinti, I. (2016) · Cellular Immunology · doi:10.1016/j.cellimm.2016.05.006 · Cited by 7
Badgett, M. J., Mize, E. M., Fletcher, T., Boyes, B. E., & Orlando, R. (2018) · Journal of Biomolecular Techniques JBT · doi:10.7171/jbt.18-2904-002 · Cited by 7
Lewis, B. J. B., & Branch, D. R. (2020) · Pharmacology · doi:10.1159/000508239 · Cited by 7
Kinoshita, M., Nakajima, K., Yamamoto, S., & Suzuki, S. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03434-0 · Cited by 8
Ivanova, A., & Falcioni, F. (2022) · Frontiers in Catalysis · doi:10.3389/fctls.2021.810779 · Cited by 5
Willis, E. F., Gillespie, E. R., Guse, K., Zuercher, A., Käsermann, F., Ruitenberg, M., & Vukovic, J. (2022) · Brain, behavior, and immunity · doi:10.1016/j.bbi.2022.12.018 · Cited by 6
Fokkink, W. R., Selman, M. H. C., Wuhrer, M., & Jacobs, B. C. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12530 · Cited by 7
Stangel, M. (2008) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285608095747 · Cited by 7
Designing an Artificial Golgi reactor to achieve targeted glycosylation of monoclonal antibodies
Victorovich, K. O., Shah, N., Kontoravdi, C., Royle, K. E., & Polizzi, K. M. (2016) · AIChE Journal · doi:10.1002/aic.15388 · Cited by 6
Wu, Q.-Q., Yang, Y., Xie, D., Li, S.-X., Liu, Y., Shu, L.-J., Fu, G., Xu, Y., & Ji, P. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.07.055 · Cited by 8
Acute RNA Viral Encephalomyelitis and the Role of Antibodies in the Central Nervous System
Bartlett, M. L., & Griffin, D. E. (2020) · Viruses · doi:10.3390/v12090988 · Cited by 7
Application of Genetic Engineering in Biotherapeutics Development
Schweickert, P. G., & Cheng, Z. (2019) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-019-09411-6 · Cited by 8
Sibley, T. A., Miller, M. M., & Fogle, J. E. (2012) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2012.11.013 · Cited by 7
Coillie, S. V., Prevot, J., Sánchez‐Ramón, S., Lowe, D. M., Borg, M., Autran, B., Segundo, G. R. S., Pecoraro, A., Garcelon, N., Boersma, C., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1430678 · Cited by 6
ESAT-6 and CFP-10 reactive IgG in patients with tuberculosis inhibits intracellular bacteria
Miles, J., Lu, P., Bai, S., Aguillón-Durán, G. P., Rodríguez-Herrera, J. E., Gunn, B. M., Restrepo, B. I., & Lu, L. L. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116653 · Cited by 9
COVID myocarditis: a review of the literature
Cersosimo, A., Pasquale, M. D., Arabia, G., Metra, M., & Vizzardi, E. (2023) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2023.2784 · Cited by 7
Sotomayor, B., Donahue, T. C., Mahajan, S. P., Taw, M. N., Hulbert, S. W., Bidstrup, E. J., Owitipana, D. N., Pang, A., Xu, Y., Ghosal, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61440-7 · Cited by 7
Jin, J., Gong, J., Lin, B., Li, Y., & He, Q. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.03.006 · Cited by 6
Wang, Y., Lin, S., Wu, J., Jiang, M., Lin, J., Zhang, Y., Ding, H., Zhou, H., Shen, N., & Di, W. J. (2023) · Frontiers of Medicine · doi:10.1007/s11684-022-0965-7 · Cited by 6
Zhang, K., Yu, H., Xie, W., Xu, Z., Zhou, S., Huang, C., Sheng, H., He, X., Xiong, J., & Qian, G. (2013) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2013.01.015 · Cited by 6
Batard, T., Zimmer, A., Nony, E., Bouley, J., Airouche, S., Luce, S., Turfkruyer, M., Tourdot, S., Mascarell, L., & Moingeon, P. E. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.049 · Cited by 6
Afonso, A. B., Justo, L. N., Queirós, A. C., Fesel, C., Cabral, M. S., da Silva, M. G., Porrata, L. F., Markovic, S. N., Pires, A. E., & Joao, C. M. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9802-0 · Cited by 6
Platelet Glycobiology and the Control of Platelet Function and Lifespan
Giannini, S., Falet, H., & Hoffmeister, K. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813456-6.00004-7 · Cited by 6
Rebello, O. D., Gardner, R. A., Urbanowicz, P. A., Bolam, D. N., Crouch, L. I., Falck, D., & Spencer, D. I. R. (2020) · Glycoconjugate Journal · doi:10.1007/s10719-020-09953-9 · Cited by 6
Methods for the High Resolution Analysis of Glycoconjugates
Gray, C., & Flitsch, S. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-65587-1_11 · Cited by 6
Therapieoptimierung bei schweren bullösen Autoimmundermatosen
Schmidt, E. (2009) · Der Hautarzt · doi:10.1007/s00105-008-1680-2 · Cited by 6
Estrogen Modulation of B Cell Immunity: Implications for HIV Control and Therapeutic Strategies
Kasibante, J., Brown, T. T., Lake, J. E., & Abdel‐Mohsen, M. (2025) · Comprehensive physiology · doi:10.1002/cph4.70050 · Cited by 7
Advances and challenges in plant N-glycoengineering: when fucosylation matters
Gauba, K., Kunnummel, V., & Castilho, A. (2025) · Frontiers in Plant Science · doi:10.3389/fpls.2025.1734060 · Cited by 5
Petralia, L. M. C., Santha, E., Behrens, A., Nguyen, D. L., Ganatra, M. B., Taron, C. H., Khatri, V., Kalyanasundaram, R., van Diepen, A., Hokke, C. H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-19964-1 · Cited by 5
Soluble markers of viral rebound and post-treatment HIV control
Giron, L. B., Pasternak, A. O., & Abdel‐Mohsen, M. (2024) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000889 · Cited by 5
Soluble Factors and Mechanisms Regulated by Sialylated IgG Signaling
Edwards, D. L., Huang, M., & Wang, T. T. (2025) · Immunological Reviews · doi:10.1111/imr.70021 · Cited by 5
“Lost sugars” — reality of their biological and medical applications
Talafová, K., & Nahálka, J. (2012) · Open Life Sciences · doi:10.2478/s11535-012-0079-3 · Cited by 4
Role of Intravenous Immunoglobulin in Dermatologic Disorders
Amber, K. T., Shiu, J., Ferris, K. M., & Grando, S. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-66884-0_39 · Cited by 5
Low amounts of bisecting glycans characterize cerebrospinal fluid-borne IgG
Knopf, J., Magorivska, I., Maler, J. M., Spitzer, P., Bilyy, R. O., Biermann, M. H. C., Hychka, К. М., Bondt, A., Wuhrer, M., Toes, R. E. M., et al. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.04.010 · Cited by 5
Anti-inflammatory Activity of IgG-Fc
Beneduce, C., Kurtagic, E., & Bosques, C. J. (2019) · Current topics in microbiology and immunology · doi:10.1007/82_2019_148 · Cited by 5
Giron, L. B., Azzoni, L., Yin, X., Lynn, K., Ross, B. N., Fair, M. G., Damra, M., Sciorillo, A., Liu, Q., Jacobson, J. M., et al. (2020) · AIDS · doi:10.1097/qad.0000000000002558 · Cited by 5
Baksmeier, C., Blundell, P. A., Steckel, J., Schultz, V., Gu, Q., Filipe, A. D. S., Kohl, A., Linnington, C., Lu, D., Dell, A., et al. (2021) · Immunology · doi:10.1111/imm.13341 · Cited by 5
Cell Surface Enzymatic Engineering-Based Approaches to Improve Cellular Therapies
Abuelela, A. F., Sakashita, K., & Merzaban, J. S. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-3146-6.00009-x · Cited by 5
Enhancement of sialylation in rIgG in glyco-engineered Chinese hamster ovary cells
Nguyen, T. S., Misaki, R., Ohashi, T., & Fujiyama, K. (2020) · Cytotechnology · doi:10.1007/s10616-020-00381-z · Cited by 5
Glycosylation of Structured Protein Domains in Cell-Free Reaction Environments
Bidstrup, E. J., Hill, K., Bandi, C. K., Owitipana, D. N., Chisti, A., Aw, R., Xu, Y., Azadi, P., Jewett, M. C., Wang, L., et al. (2025) · ACS Synthetic Biology · doi:10.1021/acssynbio.5c00229 · Cited by 4
Pharmaceutical protein production by transgenic chickens: several viewpoints towards the next stage
Nishijima, K., & Okuzaki, Y. (2026) · Protein Expression and Purification · doi:10.1016/j.pep.2026.106900 · Cited by 4
Ni, X., Murray, N. B., Archer‐Hartmann, S. A., Pepi, L. E., Helm, R. F., Azadi, P., & Hong, P. (2023) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.3c00132 · Cited by 4
Unveiling the N-Glycomic Diversity of Goat Lactoferrin during Lactation
Zhang, Y., Han, T., Zhang, L., Yun, S., Yuan, Y., Wang, X., Huang, L., Wang, Z., & Lu, Y. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c10346 · Cited by 4
Sequence-controlled glycooligomers for tumor targeting
Chen, J., Zhang, Y., Gao, Q., Wang, W. J., Zhu, L., Khedr, G. E., Xing, Q., Shi, W., & Geng, J. (2023) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2023.101749 · Cited by 4
Glycosylation in autoimmune diseases: A bibliometric and visualization study
Deng, G., Chen, X., Le, S., Wu, Q., & Wang, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30026 · Cited by 4
Molecular determinants of sialylated IgG anti-inflammatory activity
Sneed, S. L., Strandberg, E. A., Laureano, A. F. S., Vattepu, R., Sun, Y., Tran, T. T., Conroy, M. E., & Anthony, R. M. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2411600122 · Cited by 4
Self-citationRostyslav, B., Tomin, A., Tolstyak, Y., Havrylyuk, A. M., Valentina, C., Кит, Ю. Я., & Стойка, Р. С. (2011) · InTech eBooks · doi:10.5772/21041 · Cited by 4
Yu, X., Baruah, K., Scanlan, C. N., & Crispin, M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394802-1.00010-8 · Cited by 4
Wawrzyniak, M., Morsy, Y., Mladenov, R., Tontodonati, G., Turgay, Y., Herwig, S., Back, J., Mally, M., Faridmoayer, A., & Scharl, M. M. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab038 · Cited by 4
Rapid Antibody Glycoengineering in CHO Cells Via RNA Interference and CGE-LIF N-Glycomics
Kotidis, P., Marbiah, M. M., Donini, R., Gómez, I. A., del Val, I. J., Haslam, S. M., Polizzi, K. M., & Kontoravdi, C. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1685-7_7 · Cited by 3
Total serum N-glycans mark visceral leishmaniasis in human infections with Leishmania infantum
Porcino, G. N., Bladergroen, M. R., Dotz, V., Nicolardi, S., Memarian, E., Gardinassi, L. G., Costa, C. H. N., de Almeida, R. P., Santos, I. K. F. D. M., & Wuhrer, M. (2023) · iScience · doi:10.1016/j.isci.2023.107021 · Cited by 4
Long-Term Culturing of FreeStyle 293-F Cells Affects Immunoglobulin G Glycome Composition
Lukšić, F., Mijakovac, A., Josipović, G., Bočkor, V. V., Krištić, J., Cindrić, A., Vinicki, M., Rokić, F., Vugrek, O., Lauc, G., et al. (2023) · Biomolecules · doi:10.3390/biom13081245 · Cited by 4
Lauc, G. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2277218 · Cited by 4
Piperidine-based glycodendrons as protein N-glycan prosthetics
Hudak, J. E., Belardi, B., Appel, M. J., Solania, A., Robinson, P. V., & Bertozzi, C. R. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.05.050 · Cited by 4
Targeting Glycans of HIV Envelope Glycoproteins for Vaccine Design
Behrens, A., Seabright, G. E., & Crispin, M. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781782623823-00300 · Cited by 4
Immunoglobulin G Glycosylation in Diseases
Pezer, M. (2021) · Experientia supplementum · doi:10.1007/978-3-030-76912-3_13 · Cited by 4
Reply to Bayry et al.: The anti-inflammatory activity of sialylated IgG Fcs
Ravetch, J. V., Anthony, R. M., Wermeling, F., & Karlsson, M. C. I. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900445106 · Cited by 4
Self-citationTsukamoto, Y., Aoki, K., Kama, Y., Hosokawa, H., Saiki, W., Tsukamoto, N., Kato, K., Hosokawa, Y., Sato, R., Uesugi, N., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2504827122 · Cited by 3
Lai, K., He, P., He, Y., Xu, M., Zhao, X., Wang, X., Miao, G., Feng, Y., & Wang, X. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-026-01661-3 · Cited by 5
Future perspectives in myasthenia gravis (Review)
Golfinopoulou, R., Papakonstantinou, E., & Vlachakis, D. (2023) · International Journal of Epigenetics · doi:10.3892/ije.2023.16 · Cited by 3
Activity Determination of Glycosyltransferases
Anumula, K. R. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9055-9_7 · Cited by 3
Plant Platform for Therapeutic Monoclonal Antibody Production
Dorokhov, Y., Шешукова, Е. В., & Komarova, T. (2019) · Plant Biotechnology · doi:10.1007/978-981-13-8499-8_24 · Cited by 1
Stockdale, L. K., de Haan, N., Hill, J. W., Johnson, M., Tomić, A., Wuhrer, M., Jones, E. A., Jin, C., Nouta, J., Koeleman, C. A. M., et al. (2022) · Frontiers in Analytical Science · doi:10.3389/frans.2022.1005558 · Cited by 3
Li, M., Arjomandi, A., Sun, X., Lu, E., Tyagi, T., Lin, W., Fischer, S. K., Kaur, S., & Xu, K. (2023) · The AAPS Journal · doi:10.1208/s12248-023-00878-3 · Cited by 3
Choi, H., Lee, H.-E., Lee, S.-V., Joo, J.-S., Baek, H., Kim, S.-K., Park, M., Lee, S.-W., Yang, S.-W., Hwang, H. S., et al. (2024) · Experimental Eye Research · doi:10.1016/j.exer.2024.109782 · Cited by 3
Changes in the N-glycosylation of porcine immune globulin G during postnatal development
Zlatina, K., Isernhagen, L., Galuska, C. E., Muráni, E., & Galuska, S. P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1361240 · Cited by 3
Freezing influences, the exposure of IgG glycans in sera from multiple sclerosis patients
Боженко, М. І., Boichuk, M. O., Bila, G., Nehrych, T. I., & Bilyy, R. O. (2020) · The Ukrainian Biochemical Journal · doi:10.15407/ubj92.02.021 · Cited by 3
Gamain, B., Brousse, C., Rainey, N. E., Diallo, B., Paquereau, C.-E., Desrames, A., Ceputyte, J., Semblat, J., Bertrand, O., Gangnard, S., et al. (2022) · Science Advances · doi:10.1126/sciadv.abl4363 · Cited by 3
Fillatreau, S. (2014) · European Journal of Immunology · doi:10.1002/eji.201444561 · Cited by 3
INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS
Лазанович, В. А., & Prosekova, E. V. (2014) · Medical Immunology (Russia) · doi:10.15789/1563-0625-2014-4-311-322 · Cited by 3
Generation of IgG-Fc Glycovariants Using Recombinant Glycosidases and Glycosyltransferases
Quast, I., Maurer, M., & Lünemann, J. D. (2016) · BIO-PROTOCOL · doi:10.21769/bioprotoc.1886 · Cited by 3
Immune Responses to Viral Infection
Streeck, H., Suscovich, T. J., & Alter, G. (2016) · ASM Press eBooks · doi:10.1128/9781555819439.ch16 · Cited by 3
Ballow, M. C. (2013) · Elsevier eBooks · doi:10.1016/b978-0-7234-3691-1.00098-2 · Cited by 3
Verzuckerungsabhängiger Wirkmechanismus von Antikörpern
Ehlers, M. (2012) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-012-1007-7 · Cited by 3
Editorial: Sweets Are Good for You: Fine Tuning Antibodies via Glycosylation
Nigrovic, P. A. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38080 · Cited by 3
Advances in mass spectrometry-based strategies for analyzing sialic acid linkage isomers
Wu, L., Wang, M., & Gao, C. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118383 · Cited by 2
IgG Idiotype Diversity Shapes Cytokine Profiles and Autoantibody Targets in HTLV-1 Clinical Outcomes
Bergamasco, I. S., Machado, N. R., do Nascimento, L. A., Fagundes, B. O., Sgnotto, F. D. R., Casseb, J., Sanabani, S. S., Nali, L. H. D. S., Miyashiro, D., Sanches, J. A., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262210858 · Cited by 2
Selective fluorination of Fc glycans enhances antibody-mediated effector functions
Wang, X., Gomozkova, M., Li, S., Banerjee, B. N., Zong, G., Missiakas, D. M., & Wang, L. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2530653123 · Cited by 2
Basic Trajectories in Autoimmunity
Land, W. G. (2023) · Springer eBooks · doi:10.1007/978-3-031-21776-0_6 · Cited by 2
Xiao, Y., Dong, X., Chen, C., Cui, Y., Chu, T., Li, X., & Wang, A. (2023) · Journal of Chromatography B · doi:10.1016/j.jchromb.2023.123983 · Cited by 2
Stikeman, E., & Bianco, D. D. (2024) · Journal of Small Animal Practice · doi:10.1111/jsap.13700 · Cited by 2
Pranomphon, R., Tejwani, V., Dahodwala, H., Yamabhai, M., & Sharfstein, S. T. (2024) · Springer eBooks · doi:10.1007/978-3-031-62007-2_6 · Cited by 2
Role of Antibody Glycosylation in Health, Disease, and Therapy
Nimmerjahn, F. (2025) · Handbook of experimental pharmacology · doi:10.1007/164_2025_744 · Cited by 2
Self-citationMuñoz‐Grajales, C., Ucciferri, C. C., Johnson, S. R., Touma, Z., Ahmad, Z., Bonilla, D., Hiraki, L. T., BOOKMAN, A. A. M., & Wither, J. (2025) · Arthritis & Rheumatology · doi:10.1002/art.43323 · Cited by 2
Molecular and Cellular Pathways Involved in the Anti-inflammatory Activity of IgG
Nimmerjahn, F. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7107-3_5
Self-citationProspects for the use of sialylated immunoglobulins in the treatment of different diseases
Markina, Y. V., Markin, A. M., Sobenin, I. A., & Orekhov, A. N. (2020) · Fundamental and Clinical Medicine · doi:10.23946/2500-0764-2020-5-2-112-118 · Cited by 2
Boor, P., & Kunter, U. (2009) · Kidney & Blood Pressure Research · doi:10.1159/000223449 · Cited by 2
Ballow, M. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-7020-6896-6.00084-3 · Cited by 2
Metadata
- Authors
- Anthony, R. M., Nimmerjahn, F., Ashline, D. J., Reinhold, V. N., Paulson, J. C., & Ravetch, J. V.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Ravetch, Jeffrey V.
- Venue
- Science
- Published
- 2008-04-18
- Volume
- 320
- Issue
- 5874
- Pages
- 373-376
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC2409116
- OpenAlex
- W2051666192
- Cited by
- 849
- References
- 34
- Citations by year
- 2026: 19 · 2025: 32 · 2024: 29 · 2023: 37 · 2022: 39 · 2021: 39 · 2020: 50 · 2019: 39 · 2018: 45 · 2017: 46 · 2016: 66 · 2015: 58 · 2014: 58 · 2013: 58 · 2012: 68
- FWCI
- 42.36
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5r01gm060938-10)
- National Institute of General Medical Sciences (R01GM054045, R01-GM060938, GM60938)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- intravenous immunoglobulin, anti-inflammatory activity, IgG Fc fragment, sialylation, N-glycans, glycan engineering, autoimmune disease
- MeSH terms
- Animals, Anti-Inflammatory Agents, Non-Steroidal, Arthritis, Experimental, Autoimmune Diseases, Carbohydrate Conformation, Galactose, Glycosylation, Humans, Immunoglobulin G, Immunoglobulin Fc Fragments, Mice, Inbred C57BL, Polysaccharides, Receptors, Fc, Recombinant Proteins, Purpura, Thrombocytopenic, Idiopathic, Mice, Inbred NOD, Immunoglobulins, Intravenous, N-Acetylneuraminic Acid, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review